Last Price
81.61
Today's Change
+41.85 (105.25%)
Day's Change
47.67 - 98.00
Trading Volume
949,572
Profile
KRRO
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Ram Aiyar MBA, Ph.D. Mr. Ram Aiyar MBA, Ph.D.
Full Time Employees: 92 92
IPO Date: 2019-10-03 2019-10-03
CIK: 0001703647 0001703647
ISIN: US5009461089 US5009461089
CUSIP: 500946108 500946108
Beta: 0.00 0.00
Last Dividend: 0.00 0.00
Dcf Diff: -47.17 -47.17
Dcf: 86.93 86.93
Description
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
3
CEO Morning Brief
Emirates Blasts Boeing for Delays, Plans ‘serious Conversations’
4
CEO Morning Brief
Nvidia Rides Fierce Blackwell Demand Towards Stock Record Again
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
